Rituximab as First Choice for Patients With Refractory Rheumatoid Arthritis: Cost-Effectiveness Analysis in Iran Based on a Systematic Review and Meta-Analysis

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.2623

Related search